These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 22898839)

  • 1. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
    Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
    Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
    Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
    J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population.
    Lai MH; Luk WH; Chan JC
    Urol Oncol; 2011; 29(3):275-9. PubMed ID: 19734069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The indication of bone scan for patients with newly diagnosed prostate cancer].
    Liu D; Wang W; Qiao LD; Zheng YP; Liu YX; Zhang GY; Chen S
    Zhonghua Wai Ke Za Zhi; 2012 May; 50(5):443-5. PubMed ID: 22883953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
    Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
    Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.
    McArthur C; McLaughlin G; Meddings RN
    Br J Radiol; 2012 Apr; 85(1012):390-4. PubMed ID: 21304009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients.
    Lee N; Fawaaz R; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Singh A; Ennis RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1443-6. PubMed ID: 11121646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
    Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
    Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.
    Cher ML; Bianco FJ; Lam JS; Davis LP; Grignon DJ; Sakr WA; Banerjee M; Pontes JE; Wood DP
    J Urol; 1998 Oct; 160(4):1387-91. PubMed ID: 9751361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [When should we perform a bone scintigraphy in patients with new diagnosis of asymptomatic prostate cancer in order to detect bone metastasis?].
    Márquez-López J; Gómez-Gómez E; Anaya-Henares F; Robles-Casilda R; Requena-Tapia MJ
    Arch Esp Urol; 2015 Mar; 68(2):135-41. PubMed ID: 25774820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
    Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y
    Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study.
    Lin Y; Mao Q; Chen B; Wang L; Liu B; Zheng X; Xie L
    BMC Urol; 2017 Jun; 17(1):41. PubMed ID: 28606069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
    Pal RP; Thiruudaian T; Khan MA
    Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
    Oesterling JE; Martin SK; Bergstralh EJ; Lowe FC
    JAMA; 1993 Jan; 269(1):57-60. PubMed ID: 7677962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
    Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.